title: Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors.
authors.affiliation: Department of Cardiology and Internal Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
authors.forename: Jacek
authors.initials: J
authors.lastname: Kubica
authors.affiliation: Department of Health Promotion, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
authors.forename: Aldona
authors.initials: A
authors.lastname: Kubica
authors.affiliation: Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
authors.forename: Bernd
authors.initials: B
authors.lastname: Jilma
authors.affiliation: Department of Principles of Clinical Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland. Electronic address: piotr.adamski@wp.eu.
authors.forename: Piotr
authors.initials: P
authors.lastname: Adamski
authors.affiliation: Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
authors.forename: Eva-Luise
authors.initials: EL
authors.lastname: Hobl
authors.affiliation: Department of Internal Medicine, Division of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University, Düsseldorf, Germany.
authors.forename: Eliano Pio
authors.initials: EP
authors.lastname: Navarese
authors.affiliation: Department of Cardiology, Medical University of Vienna, Vienna, Austria.
authors.forename: Jolanta Maria
authors.initials: JM
authors.lastname: Siller-Matula
authors.affiliation: Department of Theoretical Foundations of Biomedical Science and Medical Informatics, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
authors.forename: Anita
authors.initials: A
authors.lastname: Dąbrowska
authors.affiliation: Department of Cardiology and Internal Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
authors.forename: Tomasz
authors.initials: T
authors.lastname: Fabiszak
authors.affiliation: Department of Principles of Clinical Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
authors.forename: Marek
authors.initials: M
authors.lastname: Koziński
authors.affiliation: Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Fairfax, VA, USA.
authors.forename: Paul Alfred
authors.initials: PA
authors.lastname: Gurbel
mesh_terms: D000241:Adenosine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D004347:Drug Interactions; D006801:Humans; D009020:Morphine / Q000008:administration & dosage* / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy*; D064887:Observational Studies as Topic; D000068799:Prasugrel Hydrochloride / Q000008:administration & dosage / Q000627:therapeutic use; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D000077486:Ticagrelor; D016896:Treatment Outcome
chemical_list: D058921:Purinergic P2Y Receptor Antagonists; D009020:Morphine; D000068799:Prasugrel Hydrochloride; D000077486:Ticagrelor; D000241:Adenosine
keywords: Clopidogrel; Drug–drug interaction; Morphine; Prasugrel; Ticagrelor